Dow Up 0.12% Nasdaq Up 1.35%

Amicus Therapeutics, Inc. (FOLD)

-NasdaqGM
5.94 0.33(5.88%) Oct 20, 4:00PM EDT
Prev Close:5.61
Open:5.66
Bid:5.90 x 2800
Ask:6.08 x 1100
1y Target Est:9.50
Beta:1.73
Earnings Date:Nov 10 - Nov 14 (Est.)
Day's Range:5.66 - 6.12
52wk Range:1.77 - 7.63
Volume:674,803
Avg Vol (3m):2,387,590
Market Cap:467.48M
P/E (ttm):N/A
EPS (ttm):-0.97
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for FOLD

Comparison

Symbol% ChgMkt Cap
FOLDUp 5.88%467.48M
SHPG36.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):341.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.94
Quarterly EPS Est (Sep-14) :-0.21
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback